The abstract is read at the publisher; the summary is JClub's.
Micro[nano]plastic particles have been detected across many human organs and in diverse cancer tissues, but epidemiological evidence linking exposure to cancer risk remains scarce.
- Why it matters: The field lacks standardized, reliable ways to measure human micro[nano]plastic exposure and connect it to cancer risk or cancer-related causal pathways.
- What they did: The review synthesizes findings from detection in human tissues plus evidence from in-vitro studies, in-vivo models, and occupational studies, while highlighting measurement and standardization barriers.
- The result: Improved detection and measurement technologies for micro[nano]plastics in human biological samples, alongside progress on methodological hurdles, should enable major advances in epidemiology-focused research on micro[nano]plastics and cancer.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.